Evidence map›Paper›PMID 23608320›Full record

ArticleFungal genetics and biology : FG & B2013

Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis.

Fernanda L Fonseca, Allan J Guimarães, Lívia Kmetzsch, Fabianno F Dutra, Fernanda D Silva, Carlos P Taborda, Glauber de S Araujo, Susana Frases, Charley C Staats, Marcelo T Bozza and 5 more

Open access · greenAbstract read
In one paragraph

Article in Fungal genetics and biology : FG & B, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. TheApplied and environmental microbiology · 2023
    Article
  4. Article
  5. Cell wall composition inFrontiers in fungal biology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Ultrastructural Study ofFrontiers in microbiology · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The status of cryptococcosis in Latin America.Memorias do Instituto Oswaldo Cruz · 2018
    Review
  15. Article
  16. Article
  17. Modulation of Zinc Homeostasis inFrontiers in microbiology · 2017
    Article
  18. Cryptococcal Disease in HIV-Infected Children.Current infectious disease reports · 2016
    Review
  19. Article
  20. New technology and resources for cryptococcal research.Fungal genetics and biology : FG & B · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Fernanda L FonsecaInstituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Allan J Guimarães
Lívia Kmetzsch
Fabianno F Dutra
Fernanda D Silva
Carlos P Taborda
Glauber de S Araujo
Susana Frases
Charley C Staats
Marcelo T Bozza
Augusto Schrank
Marilene H Vainstein
Leonardo Nimrichter
Arturo Casadevall
Marcio L Rodrigues
Universidade Federal do Rio de Janeiro · BRUniversidade Federal do Rio Grande do Sul · BRUniversidade de São Paulo · BRAlbert Einstein College of Medicine · USUniversidade Federal Fluminense · BR

Funding

Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
Biology of Fungal MelaninR01AI052733 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 2003 to 2019
$6.6M
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONSR01AI033774 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2014
$5.6M
Molecular Characterization of C. neoformans AntibodiesR37AI033142 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CASADEVALL, ARTURO · 2007 to 2016
$3.9M
MOLECULAR CHARACTERIZATION OF C NEOFORMANS ANTIBODIESR01AI033142 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2006
$1.7M
NHLBI NIH HHS HL059842NHLBI NIH HHS R01 HL059842NIAID NIH HHS AI033142NIAID NIH HHS AI033774NIAID NIH HHS AI052733NIAID NIH HHS R01 AI033142NIAID NIH HHS R01 AI033774NIAID NIH HHS R01 AI052733NIAID NIH HHS R37 AI033142
6 · The paper itself

Abstract

The principal capsular component of Cryptococcus neoformans, glucuronoxylomannan (GXM), interacts with surface glycans, including chitin-like oligomers. Although the role of GXM in cryptococcal infection has been well explored, there is no information on how chitooligomers affect fungal pathogenesis. In this study, surface chitooligomers of C. neoformans were blocked through the use of the wheat germ lectin (WGA) and the effects on animal pathogenesis, interaction with host cells, fungal growth and capsule formation were analyzed. Treatment of C. neoformans cells with WGA followed by infection of mice delayed mortality relative to animals infected with untreated fungal cells. This observation was associated with reduced brain colonization by lectin-treated cryptococci. Blocking chitooligomers also rendered yeast cells less efficient in their ability to associate with phagocytes. WGA did not affect fungal viability, but inhibited GXM release to the extracellular space and capsule formation. In WGA-treated yeast cells, genes that are involved in capsule formation and GXM traffic had their transcription levels decreased in comparison with untreated cells. Our results suggest that cellular pathways required for capsule formation and pathogenic mechanisms are affected by blocking chitin-derived structures at the cell surface of C. neoformans. Targeting chitooligomers with specific ligands may reveal new therapeutic alternatives to control cryptococcosis.

Indexed as

AnimalsBrainChitinCryptococcosisCryptococcus neoformansFungal CapsulesMacrophagesMiceMice, Inbred C57BLPhagocytosisPolysaccharidesWheat Germ AgglutininsChitinglucuronoxylomannanPolysaccharidesWheat Germ AgglutininsCapsuleChitin oligosaccharidesCryptococcus neoformansLectin bindingVirulence

Identifiers

PMID23608320
PMCPMC4294701
OpenAlexW1981732662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.